ClinicalTrials.govpublic full text
INST Phase II Trial of Gemcitabine and Irinotecan in Patients With Relapsed or Refractory Lymphoma.
non-hodgkin's lymphoma, cancer, lymphoma-non hodgkins, phase ii, gemcitabine, irinotecan, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 803246
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.